Final answer:
The storage locations of drugs outside of pharmacies should be documented in accordance with FDA regulations and are typically found in health care facilities' policy and procedure manuals. The FDA protects against unsafe drugs through stringent regulations, but prolonged testing can delay drug availability, negatively affecting patients in urgent need of new treatments.
Step-by-step explanation:
If drugs are stored in areas other than the pharmacy, the location and information regarding the storage should always adhere to the regulations set by relevant health authorities, such as the Food and Drug Administration (FDA). This information is typically detailed in policy and procedure manuals within health care facilities. It is crucial to document the storage locations to ensure proper management and auditing of pharmaceuticals, maintain drug safety and efficacy, and to comply with legal regulations regarding drug storage and dispensing.
Regarding the FDA's role in drug regulation, the agency ensures that pharmaceuticals sold in the United States are safe and effective. While the FDA's regulations protect consumers from potentially unsafe drugs, there can be drawbacks. Prolonged testing periods required before a drug reaches the market can delay access to potentially lifesaving drugs, resulting in what might be considered 'anonymous losers' in the system. These 'losers' are patients and individuals who may suffer from diseases that could benefit from innovative treatments that are not yet available due to the stringent and lengthy approval process.